Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice
Guardado en:
Autores principales: | Concetta Panebianco, Federica Pisati, Maria Ulaszewska, Annapaola Andolfo, Annacandida Villani, Federica Federici, Manna Laura, Eleonora Rizzi, Adele Potenza, Tiziana Pia Latiano, Francesco Perri, Claudio Tripodo, Valerio Pazienza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77b00ca2677f4229bc81f25964a4332b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma
por: Stefanie Schwinn, et al.
Publicado: (2021) -
The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine
por: Shan-Ming Chen, et al.
Publicado: (2020) -
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
por: Panagiotis A. Konstantinopoulos, et al.
Publicado: (2021) -
Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression
por: Guo ZY, et al.
Publicado: (2018) -
RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
por: Liu W, et al.
Publicado: (2019)